AnalystsNathan TreybeckNathan Treybeck's Stock Forecasts
AnalystsNathan Treybeck
Sectors:
Analyst Ranking
Top 31%
#1524 out of 4929 analysts
Average Return
+17.21%
Win Rate
64%7 out of 11
Risk vs Reward
Poor
Good
Nathan Treybeck's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Procept Biorobotics CorpPRCT | +121.48% | $40.55 | $89.81 | 2023-12-13 - 2024-12-12 | Strong Buy |
Procept Biorobotics CorpPRCT | +77.90% | $48.60 | $86.46 | 2024-01-09 - 2025-01-08 | Strong Buy |
Procept Biorobotics CorpPRCT | +38.88% | $33.90 | $47.08 | 2023-01-12 - 2024-01-11 | Strong Buy |
Nevro CorpNVRO | +11.80% | $4.83 | $4.26 | 2024-08-07 - 2024-12-03 | Strong Sell |
Irhythm Technologies IncIRTC | +9.67% | $108.72 | $119.23 | 2023-02-07 - 2024-02-06 | Strong Buy |
Nathan Treybeck Analyst Color
Get additional color on Nathan Treybeck's coverage of popular stocks
Nathan Treybeck's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Irhythm Technologies IncIRTC | 4 | Strong Buy | $130.00 | -8.75% | Upgrades | 2 months ago |
Lemaitre Vascular IncLMAT | 1 | Hold | $95.00 | +12.57% | Initiates Coverage On | 5 months ago |
Nevro CorpNVRO | 4 | Hold | $4.00 | -31.51% | Maintains | 7 months ago |
Procept Biorobotics CorpPRCT | 7 | Strong Buy | $112.00 | +93.37% | Reinstates | 7 months ago |
Integer Holdings CorpITGR | 2 | Strong Buy | $160.00 | +32.23% | Reinstates | 7 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.